86 trends tracked about this subject — the full history, oldest to newest below.
New research indicates that GLP-1 medications like Ozempic and Wegovy may significantly reduce the frequency of asthma attacks and COPD flare-ups.
A new observational study links weight regain following the use of obesity medications to an increased risk of suicidal thoughts.
Concerns grow over the efficacy of weight-loss injections and the severe withdrawal-like cravings some patients experience when the drugs fail.
New reports suggest popular GLP‑1 weight‑loss drugs may trigger male pattern baldness, sparking medical and public‑interest scrutiny.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies indicate that GLP-1 weight loss medications may worsen or accelerate hair loss in men.
A growing cultural and medical debate is emerging over the use of GLP-1 medications, focusing on the tension between clinical benefits and social stigma.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Experts call for safer weight loss methods as public and medical attention intensifies around the use and effectiveness of GLP-1 medications.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Ozempic, a popular weight‑loss drug, is now being linked to benefits for serious mental illnesses such as bipolar disorder.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent discussions highlight a shift in the narrative surrounding weight-loss drugs, focusing on gender dynamics and the desire for medical privacy.
New scientific discoveries regarding brain circuits may redefine the understood mechanism of GLP-1 weight loss drugs like Ozempic and Wegovy.
Researchers are investigating unexpected health benefits of GLP-1 medications as the drugs evolve beyond their primary use for weight loss.
The Department of Veterans Affairs is launching a study to determine if GLP-1 medications can be used to treat alcohol use disorder in veterans.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A new study reveals that a low-fat vegan diet reduces dietary energy density by nearly a third, facilitating weight loss without conscious calorie cutting.
Regulators receive hundreds of reports linking popular weight-loss drugs to deaths.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Novo Nordisk’s once‑dominant GLP‑1 weight‑loss line now faces a fierce showdown with Eli Lilly, sparking questions about Europe’s biotech edge.
8 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent studies and new lawsuits connect popular GLP-1 medications to potential risks of sudden vision loss and eye disease.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Medical reports highlight emerging cosmetic and physical side effects linked to rapid weight loss from GLP-1 receptor agonist medications.
Recent coverage examines whether popular weight-loss drugs like GLP-1 receptor agonists offer protective benefits against cancer.
3 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Ozempic’s “temporal hollowing” side effect is sparking a surge in cosmetic procedures, prompting medical warnings.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Patients are facing restricted access to GLP-1 drugs like Ozempic and Wegovy due to high costs and restrictive insurance policies.
GLP-1 injections face new scrutiny as coverage highlights links to a rare side effect surpassing Ozempic face in severity.
Australian regulators and medical reports link GLP-1 weight-loss drugs like Ozempic to a rare and severe risk of permanent vision loss.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research links GLP-1 weight-loss medications like Ozempic and Mounjaro to an increased risk of hair loss in patients.
GLP-1 weight-loss medications are seeing a surge in adoption among adolescents and children globally, shifting treatment patterns for youth obesity.
A Georgia woman has joined a growing lawsuit connecting popular GLP-1 weight loss drugs to a rare and blinding eye condition.
Emerging trends in GLP-1 medications highlight an expansion beyond weight loss, including therapeutic retreats and rising use among young adults.
Rapid adoption of GLP-1 weight-loss drugs is sparking new debates over adolescent use, compounded safety, and the social stigma of medication.
Medical professionals are warning that GLP-1 medications may lead to emotional flatness and a loss of zest for life in some patients.
Recent medical reviews suggest users of GLP-1 weight-loss medications may face significant weight regain after stopping treatment.
A 54-year-old woman's emergency room hospitalization after a GLP-1 overdose highlights rising public safety concerns.
Medical research is exploring the intersection of GLP-1 receptor agonists and oncology, triggering debate over their potential role in cancer treatment.
A new oral GLP-1 receptor agonist is emerging as a potent weight-loss alternative, outperforming oral Ozempic in recent clinical trials.
Medical professionals are warning GLP-1 medication users about 'Ozempic feet,' a surprising new side effect emerging alongside rapid weight loss.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Ozempic’s skin effects are sparking a wave of cosmetic concern across Gen X.
Social media discourse and emerging clinical research are converging on the long-term potential of GLP-1 agonists beyond weight management.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research is exploring whether GLP-1 weight loss medications like Ozempic can slow the biological aging process and increase human longevity.
GLP-1 weight‑loss drugs spark a wave of research, clinical guidance and market buzz as they expand beyond obesity treatment.